TeloPoint is excited to announce its partnership with TrialSpark. This partnership, launched in May of 2020, brings TeloPoint's in-home phlebotomy services to TrialSpark's clinical trial participants.

TrialSpark, an alternative to traditional CROs, uses their groundbreaking technologies and full-service clinical strategy to conduct decentralized clinical trials. Their Direct Data Capture platform, Pilot, and nationwide physician network bring clinical research to the 98% of physicians and patients that the industry has historically failed to include.

‍

The inconvenience of going to the doctor’s office for a blood draw drives down participants’ lab test adherence, which increases participant drop-out and overall trial expenses. This has been exacerbated by safety concerns of being out in public due to COVID-19. By moving biological specimen collection into participants’ homes, their trial participation can continue without attrition-related delays, reducing the overall cost while delivering unmatched patient convenience and safety.

Together with TrialSpark, TeloPoint is revolutionizing how clinical trials are conducted by making it easier for participants to take control of their care from their home.